Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Gene Therapy - An Introduction
     3.1 Classification of Gene Therapy Techniques
     3.2 Physical Methods of Gene Transfer
            3.2.1 Electroporation
            3.2.2 Hydrodynamic
            3.2.3 Microinjection
            3.2.4 Particle Bombardment
            3.2.5 Ultrasound-mediated Transfection
     3.3 Vectors for Gene Therapy
            3.3.1 Adenoviral Vectors
            3.3.2 Adeno-associated Virus Vectors
            3.3.3 Retroviral Vectors
            3.3.4 Lentiviral Vectors
            3.3.5 Plasmid DNA

4. Industry Trends and Drivers
     4.1 Gene Silencing: Gaining Momentum
     4.2 Advanced Therapies: Combining Gene Therapy and Stem Cell Technology
     4.3 Immunodeficiency Syndromes: The Focus of Gene Therapy
     4.4 Nanotechnology: Empowering Gene Therapy
     4.5 Gene Therapy: A New Hope to Treat Blindness

5. Gene Therapy Clinical Trial Assessment
     5.1 By Geography
     5.2 By Indication
     5.3 By Gene Type
     5.4 By Vector
     5.5 By Clinical Trial Phase

6. Industry Overview
     6.1 Market Size and Growth
     6.2 By Application
            6.2.1 Oncology
                       6.2.1.1 Key Approaches
                       6.2.1.2  Recent Advancements
            6.2.2 Infectious Diseases
                      6.2.2.1 Key Approaches
                      6.2.2.2  Recent Advancements
            6.2.3 Genetic Disorders
                      6.2.3.1 Key Approaches
                      6.2.3.2  Recent Advancements
            6.2.4 Cardiovascular Disorders
                       6.2.4.1 Key Approaches
                       6.2.4.2  Recent Advancements
            6.2.5 Diabetes Mellitus
                       6.2.5.1 Key Approaches
                       6.2.5.2  Recent Advancements
            6.2.6 Neurological Disorders
                       6.2.6.1 Key Approaches
                       6.2.6.2  Recent Advancements
     6.3 Key Geographical Markets
            6.3.1 US
                       6.3.1.1 Regulatory Landscape
                       6.3.1.2  Recent Advancements
            6.3.2 Europe
                       6.3.2.1 Regulatory Landscape
                       6.3.2.2  Recent Advancements
            6.3.3 Australia
                       6.3.3.1 Regulatory Landscape
                       6.3.3.2  Recent Advancements
            6.3.4 Canada
                       6.3.4.1 Regulatory Landscape
                       6.3.4.2  Recent Advancements
            6.3.5 Japan
                       6.3.5.1 Regulatory Landscape
                       6.3.5.2  Recent Advancements
            6.3.6 China
                       6.3.6.1 Regulatory Landscape
            6.3.7 India
                       6.3.7.1 Regulatory Landscape
                       6.3.7.2  Recent Advancements
     6.4 Advanced Gene Therapy Drugs
            6.4.1 Collategene
            6.4.2 Allovectin-7
            6.4.3 Generx

7. Key Players Analysis
     7.1 AnGes MG, Inc
     7.2 Ark Therapeutics
     7.3 Ceregene, Inc
     7.4 Cobra Biologics
     7.5 GenVec, Inc
     7.6 Genzyme Corporation
     7.7 Vical, Inc
     7.8 Oxford BioMedica